Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TK-641 Phase 3 Study in Cancer Pain
jRCT2080221351Phase 3
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxycodone in cancer pain, sponsored by Teikoku Seiyaku Co., Ltd.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT2080221351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221351.